Cardiovascular Considerations of JAK Inhibitors in Patients With Hematologic Malignancies
- DOI
- 10.1016/j.jaccao.2026.07.010
- Published
- 2026-09
- Container
- JACC: CardioOncology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jaccao.2026.07.010,
title = {Cardiovascular Considerations of JAK Inhibitors in Patients With Hematologic Malignancies},
author = {Orly Leiva and Monica Ferrante and Sydney Lupo and Angie E. Seo and Gabriela Hobbs and Michelle Bloom and Michael Garshick},
year = {2026},
journal = {JACC: CardioOncology},
doi = {10.1016/j.jaccao.2026.07.010},
url = {https://doi.org/10.1016/j.jaccao.2026.07.010}
}RIS
TY - JOUR TI - Cardiovascular Considerations of JAK Inhibitors in Patients With Hematologic Malignancies AU - Orly Leiva AU - Monica Ferrante AU - Sydney Lupo AU - Angie E. Seo AU - Gabriela Hobbs AU - Michelle Bloom AU - Michael Garshick PY - 2026 JO - JACC: CardioOncology DO - 10.1016/j.jaccao.2026.07.010 UR - https://doi.org/10.1016/j.jaccao.2026.07.010 ER -
APA
Leiva, O., Ferrante, M., Lupo, S., Seo, A. E., Hobbs, G., Bloom, M., & Garshick, M. (2026). Cardiovascular Considerations of JAK Inhibitors in Patients With Hematologic Malignancies. JACC: CardioOncology. https://doi.org/10.1016/j.jaccao.2026.07.010
Source records
- crossref · retrieved 2026-09-26T12:28:30.142Z